Especially in MDS, where pyroptosis might be responsible for ineffective hematopoiesis and cytopenia, inflammasome targeting up-stream of IL-1β, at the level of caspase-1 or higher, could have an additional beneficial effect compared to targeting IL-1β alone. Here, CASP1 is linked to myelodysplastic syndrome.